Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 26, 2024Journal of Microbiology Immunology and InfectionOpen Access

Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV

View Full Paper
Ask AI
Bookmark
Share

Authors

WLWang-Da LiuMLMeng-Shuan LinHSHsin‐Yun Sun

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e778d3b6db6435876ed483https://doi.org/10.1016/j.jmii.2024.02.004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV: a nationwide prospective cohort study in the Netherlands2022 · 8 citations
  2. 2Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection2024 · 3 citations
  3. 3Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV2022 · 32 citations
  4. 4Humoral Immunogenicity of SARS-CoV-2 mRNA Primary Vaccination Among People with HIV2026
  5. 5Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination2024 · 15 citations